Description

Leon-Velarde et al reported criteria for high-altitude pulmonary hypertension (HAPH). The statement was delivered by an ad hoc committee formed by the International Society for Mountain Medicine at the VI World Congress on Mountain Medicine and High Altitude Physiology held in 2004 in Xining, China (which is in Qinghai Province).


 

Synonym: high-altitude heart disease, chronic mount sickness of the vascular type

 

Criteria for diagnosis:

(1) residence at an altitude > 2,500 meters.

(2) at the altitude of residence the mean pulmonary artery pressure is > 30 mm Hg OR the systolic pulmonary artery pressure is > 50 mm Hg.

(3) right ventricular hypertrophy.

(4) heart failure.

(5) moderate hypoxemia

(6) absence of excessive erythrocytosis (male with hemoglobin < 21 g/dL, female with hemoglobin < 19 g/dL)

(7) exclusion of other causes of pulmonary hypertension

 

where:

• For infants up to 6 months of age mean pulmonary artery pressure > 50 mm Hg and systolic pulmonary artery pressure > 65 mm Hg.

• For children up to 5 years of age the mean and systolic pulmonary artery pressures are intermediate.

 

Clinical and radiologic findings:

(1) cough

(2) dyspnea

(3) cyanosis

(4) sleep disturbances

(5) irritability

(6) cardiomegaly with enlargement of right atrium and ventricle

(7) prominent peripheral pulmonary arteries

(8) signs of right heart failure

 


To read more or access our algorithms and calculators, please log in or register.